SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (61)5/16/2001 5:48:35 PM
From: Biomaven  Respond to of 1840
 
I posted about the LGND Targretin trial in NSCLC (and some other trials) from ASCO over on the valuation thread:

Message 15809688

Peter



To: keokalani'nui who wrote (61)5/16/2001 11:18:06 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1840
 
Any info on doses tested in PIb phase? What are recommended doses for PIIa?

<<I'm surprised if they can get any work done before May 25.>>

Last time they were totally unprepared for AC, and FDA saved their face. Hope they learned lesson.

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News